Markus M Weck - JoVE Visualize

Showing results (1-10 of 12) with videos related to

Pageof 2

Sort By:

Experimental Hematology|November 9, 2002

Molecular and functional characterization of human Dectin-1Frank Grünebach, Markus M Weck, Jeannette Reichert, et al.

Blood|December 29, 2005

Epithelial-specific transcription factor ESE-3 is involved in the development of monocyte-derived DCsSilke Appel, Anita Bringmann, Frank Grünebach, et al.

Blood|August 18, 2005

PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathwaysSilke Appel, Valdete Mirakaj, Anita Bringmann, et al.

Cancer Gene Therapy|May 7, 2005

Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytesFrank Grünebach, Katrin Kayser, Markus M Weck, et al.

Blood|August 19, 2007

hDectin-1 is involved in uptake and cross-presentation of cellular antigensMarkus M Weck, Silke Appel, Daniela Werth, et al.

Blood|December 25, 2004

Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro-transcribed MUC1 RNADaniela Dörfel, Silke Appel, Frank Grünebach, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|October 13, 2005

Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responsesAnnkristin Heine, Frank Grünebach, Tobias Holderried, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005

Effects of imatinib on monocyte-derived dendritic cells are mediated by inhibition of nuclear factor-kappaB and Akt signaling pathwaysSilke Appel, Anette Rupf, Markus M Weck, et al.

Blood|February 11, 2003

Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cellsSusanne M Schmidt, Kerstin Schag, Martin R Müller, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004

Identification of C-met oncogene as a broadly expressed tumor-associated antigen recognized by cytotoxic T-lymphocytesKerstin Schag, Susanne M Schmidt, Martin R Müller, et al.

Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:

Pageof 2

Experimental Hematology|November 9, 2002

Molecular and functional characterization of human Dectin-1Frank Grünebach, Markus M Weck, Jeannette Reichert, et al.

Blood|December 29, 2005

Epithelial-specific transcription factor ESE-3 is involved in the development of monocyte-derived DCsSilke Appel, Anita Bringmann, Frank Grünebach, et al.

Blood|August 18, 2005

PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathwaysSilke Appel, Valdete Mirakaj, Anita Bringmann, et al.

Cancer Gene Therapy|May 7, 2005

Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytesFrank Grünebach, Katrin Kayser, Markus M Weck, et al.

Blood|August 19, 2007

hDectin-1 is involved in uptake and cross-presentation of cellular antigensMarkus M Weck, Silke Appel, Daniela Werth, et al.

Blood|December 25, 2004

Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro-transcribed MUC1 RNADaniela Dörfel, Silke Appel, Frank Grünebach, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|October 13, 2005

Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responsesAnnkristin Heine, Frank Grünebach, Tobias Holderried, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005

Effects of imatinib on monocyte-derived dendritic cells are mediated by inhibition of nuclear factor-kappaB and Akt signaling pathwaysSilke Appel, Anette Rupf, Markus M Weck, et al.

Blood|February 11, 2003

Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cellsSusanne M Schmidt, Kerstin Schag, Martin R Müller, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004

Identification of C-met oncogene as a broadly expressed tumor-associated antigen recognized by cytotoxic T-lymphocytesKerstin Schag, Susanne M Schmidt, Martin R Müller, et al.

Pageof 2